Synonyms:indapamide, 26807-65-8, Noranat, Veroxil, Tertensif, Lozol, Indaflex, Arifon, Fludex, Indamol, Bajaten, Ipamix, Tandix, Natrilix, Damide, Pressurai, Indapamida, Indapamidum, Natrix, Indapamidum [INN-Latin], Indapamida [INN-Spanish], SE-1520, flupamid, indamide, 1-(4-Chloro-3-sulfamoylbenzamido)-2-methylindoline, Indapamide (Lozol), Fludin, Lorvas, 4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide, S-1520, Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)-, 4-Chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide, FLUBEST, Metindamide, Cormil, NSC-757075, N-(4-Chloro-3-sulfamoylbenzamido)-2-methylindoline, 4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1-yl)-3-sulfamoylbenzamide, MLS000028554, CHEBI:5893, DTXSID7044633, 26807-65-8(free base), KYD-041, BENZAMIDE, 4-CHLORO-N-(2-METHYL-1-INDOLINYL)-3-SULFAMOYL-, F089I0511L, NCGC00018172-03, SMR000058829, 4-CHLORO-N-(2-METHYLINDOLIN-1-YL)-3-SULFAMOYLBENZAMIDE, DTXCID5024633, SE 1520, RHC 2555, USV 2555, Natrix (TN), Lozol (TN), SR-01000003079, EINECS 248-012-7, MFCD00079375, BRN 1604026, UNII-F089I0511L, Hypen SR, 3-(Aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)benzamide, Indapamide [USAN:USP:INN:BAN:JAN], Spectrum_000917, INDAPAMIDE [MI], Opera_ID_110, INDAPAMIDE [INN], INDAPAMIDE [JAN], Prestwick3_000220, Spectrum2_000980, Spectrum3_000467, Spectrum4_000017, Spectrum5_000866, INDAPAMIDE [USAN], S1520, INDAPAMIDE [VANDF], CHEMBL406, Indapamide (JP17/USP), INDAPAMIDE [MART.], INDAPAMIDE [USP-RS], INDAPAMIDE [WHO-DD], SCHEMBL41303, BSPBio_000239, BSPBio_002174, KBioGR_000393, KBioSS_001397, 5-20-06-00348 (Beilstein Handbook Reference), MLS001148152, MLS002222229, MLS006011900, DivK1c_000508, SPECTRUM1500349, SPBio_001019, BPBio1_000263, GTPL7203, INDAPAMIDE [EP IMPURITY], INDAPAMIDE [ORANGE BOOK], BDBM25901, HMS501J10, KBio1_000508, KBio2_001397, KBio2_003965, KBio2_006533, KBio3_001394, INDAPAMIDE [EP MONOGRAPH], NINDS_000508, HMS1920F19, HMS2090M16, HMS2091N07, HMS2095L21, HMS2231G13, HMS3259C14, HMS3369J20, HMS3655E06, HMS3712L21, HMS3748K05, INDAPAMIDE [USP MONOGRAPH], Pharmakon1600-01500349, Indapamide 1.0 mg/ml in Methanol, AMY31945, BCP04140, HY-B0259, Tox21_110775, Tox21_113182, Tox21_302687, CCG-40198, NSC757075, s1730, STL257105, STL455045, 3-(Aminosulfonyl)-4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1-yl)benzamide, AKOS015888148, Tox21_110775_1, AB03037, AC-2073, DB00808, KS-5219, NC00568, NSC 757075, Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-l-yl)-, IDI1_000508, NCGC00018172-02, NCGC00018172-04, NCGC00018172-06, NCGC00018172-08, NCGC00018172-09, NCGC00089727-02, NCGC00089727-03, NCGC00256884-01, SBI-0051415.P003, DB-047020, AB00052021, I0730, SW198686-2, A23574, D00345, EN300-117260, AB00052021-14, AB00052021-15, AB00052021_16, AB00052021_17, Indapamide, analytical standard, for drug analysis, J-016554, Q1078392, SR-01000003079-2, SR-01000003079-3, BRD-A95869247-001-04-6, BRD-A95869247-001-14-5, Z1501485351, Indapamide, British Pharmacopoeia (BP) Reference Standard, Indapamide, European Pharmacopoeia (EP) Reference Standard, Indapamide, United States Pharmacopeia (USP) Reference Standard, 3-aminosulfonyl-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)benzamide, 4-chloro-3-aminosulphonyl-N-(2,3-dihydro2-methyl-1H-indol-1-yl)benzamide, Indapamide, Pharmaceutical Secondary Standard; Certified Reference Material, 3-(aminosulphonyl)-4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1--yl)benzamide, 3-(aminosulphonyl)-4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1-yl)benzamide, 4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1-yl)-3-sulfamoylbenzenecarboximidic acid
Pubchem:PUBCHEM:3702
Id:8daee247-1d17-5479-a116-2a869d5eeaea
Description:nan
